Literature DB >> 22497959

A comparison of in vitro methods for determining the membrane receptor expression in cell lines.

Zbynek Novy1, Pavel Barta, Jana Mandikova, Milan Laznicek, Frantisek Trejtnar.   

Abstract

INTRODUCTION: Determining the number of expressed receptors per cell (NRPC) in cell lines is an important prerequisite for many experimental procedures in biomedical research. This paper focuses on the comparison of a newly developed method of determining NRPC - the Kinetic extrapolation method (KEX) - with the standard saturation method. These two methods, both based on radiolabeled ligand-receptor binding, were compared with the data on receptor expression found using quantified western blotting.
METHODS: Four cell lines with different expressions of epidermal growth factor receptor (EGFR) were chosen for the experiment: A431, HaCaT, HCT116 and HepG2. Two radiolabeled monoclonal antibodies specific for EGFR were used as ligands: [(131)I]-cetuximab and [(131)I]-panitumumab. The classic manual technique based on the saturation of cell receptors was performed on cells seeded in 24-well plates. The KEX method uses the LigandTracer, a special instrument which detects ligand retention in real time from seeded cells onto a rotating Petri dish. The western blot analysis was performed according to the routinely used procedure.
RESULTS: A very close accordance between the manual saturation technique and the KEX method was found in all four cell lines used. The NRPC in the cell lines follows the same order using both ligands: A431>HaCaT>HCT116≈HepG2. Similarly, consistent data on EGFR expression in the studied cell lines were obtained using western blot analysis and the radiolabeled ligand binding assays.
CONCLUSIONS: The KEX method could be as similarly useful for determining receptor expression as is the classic saturation method and western blotting.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22497959     DOI: 10.1016/j.nucmedbio.2012.02.007

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  6 in total

1.  Imaging of epidermal growth factor receptor on single breast cancer cells using surface-enhanced Raman spectroscopy.

Authors:  Lifu Xiao; Sitaram Harihar; Danny R Welch; Anhong Zhou
Journal:  Anal Chim Acta       Date:  2014-06-21       Impact factor: 6.558

2.  Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen.

Authors:  Il Minn; Ying Chen; Ana P Kiess; Robert Hobbs; George Sgouros; Ronnie C Mease; Mrudula Pullambhatla; Colette J Shen; Catherine A Foss; Martin G Pomper
Journal:  J Nucl Med       Date:  2015-07-16       Impact factor: 10.057

3.  Synthesis and Characterization of an Epidermal Growth Factor Receptor-Selective RuII Polypyridyl-Nanobody Conjugate as a Photosensitizer for Photodynamic Therapy.

Authors:  Johannes Karges; Marta Jakubaszek; Cristina Mari; Kristof Zarschler; Bruno Goud; Holger Stephan; Gilles Gasser
Journal:  Chembiochem       Date:  2019-10-22       Impact factor: 3.164

4.  Quantification of cell surface proteins with bispecific antibodies.

Authors:  C Panke; D Weininger; A Haas; F Schelter; T Schlothauer; S Bader; R Sircar; H P Josel; U Baer; H Burtscher; O Mundigl; M Grote; U Brinkmann; C Sustmann
Journal:  Protein Eng Des Sel       Date:  2013-08-19       Impact factor: 1.650

5.  In vivo demonstration of an active tumor pretargeting approach with peptide nucleic acid bioconjugates as complementary system.

Authors:  Anna Leonidova; Christian Foerster; Kristof Zarschler; Maik Schubert; Hans-Jürgen Pietzsch; Jörg Steinbach; Ralf Bergmann; Nils Metzler-Nolte; Holger Stephan; Gilles Gasser
Journal:  Chem Sci       Date:  2015-06-17       Impact factor: 9.825

6.  Versatile Bispidine-Based Bifunctional Chelators for 64 CuII -Labelling of Biomolecules.

Authors:  Garima Singh; Kristof Zarschler; Sebastian Hunoldt; Irma Ivette Santana Martínez; Carmen L Ruehl; Madlen Matterna; Ralf Bergmann; Domokos Máthé; Nikolett Hegedüs; Michael Bachmann; Peter Comba; Holger Stephan
Journal:  Chemistry       Date:  2020-01-09       Impact factor: 5.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.